NCT06388733: A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
- State
- Under way
- Phase
- Phase 3
- People
- 450 planned
- Started
- 19 Jun 2024
- Primary completion
- Dec 2027
- Arms
- Arm A: Niraparib
- Results
- None posted
- 29 Apr 2024: Trial registered
- 19 Jun 2024: Trial started